|
Three Months Ended September 30,
|
|||||||||||||||
|
GAAP
|
Non-GAAP(1)
|
||||||||||||||
|
2023
|
2022
|
2023
|
2022
|
||||||||||||
|
(dollars in thousands, except EPS)
|
|||||||||||||||
Revenue
|
$
|
168,569
|
$
|
133,709
|
$
|
168,569
|
$
|
133,709
|
||||||||
Gross margin
|
52.5
|
%
|
49.3
|
%
|
52.9
|
%
|
49.4
|
%
|
||||||||
Income from operations
|
$
|
33,173
|
$
|
31,636
|
$
|
43,754
|
$
|
33,529
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
25,679
|
$
|
21,004
|
$
|
37,579
|
$
|
28,178
|
||||||||
Basic EPS
|
$
|
0.43
|
$
|
0.35
|
$
|
0.62
|
$
|
0.47
|
||||||||
Diluted EPS
|
$
|
0.39
|
$
|
0.32
|
$
|
0.57
|
$
|
0.42
|
Nine Months Ended September 30,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2023
|
2022
|
2023
|
2022
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
387,402
|
$
|
280,290
|
$
|
387,402
|
$
|
280,290
|
||||||||
Gross margin
|
50.9
|
%
|
46.3
|
%
|
51.1
|
%
|
46.4
|
%
|
||||||||
Income from operations
|
$
|
72,465
|
$
|
42,365
|
$
|
87,131
|
$
|
47,601
|
||||||||
Net income attributable to ACM Research, Inc.
|
$
|
59,649
|
$
|
27,454
|
$
|
78,743
|
$
|
42,252
|
||||||||
Basic EPS
|
$
|
0.99
|
$
|
0.46
|
$
|
1.31
|
$
|
0.71
|
||||||||
Diluted EPS
|
$
|
0.90
|
$
|
0.41
|
$
|
1.19
|
$
|
0.64
|
(1) |
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial
Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized loss on short-term investments.
|
• |
Shipments. Total shipments in the third quarter of 2023 were $213 million, up 31% from the third quarter of 2022. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting
customer acceptance for potential revenue in future quarters.
|
• |
Receipt of Purchase Order for Backside Clean and Bevel Etch Tool from Large U.S. Manufacturer. ACM announced the receipt of a purchase order for its ULTRA C b backside clean and bevel etch tool from a major U.S. semiconductor manufacturer. The tool is expected to be shipped to the prospective customer’s U.S.
facility in the second quarter of 2024.
|
• |
Introduced Vacuum Cleaning Platform. ACM introduced the ULTRA C
v Vacuum Cleaning Tool to meet the unique flux removal requirements for chiplets and other advanced 3D packaging structures. The new tool, which was developed in collaboration with several key customers, has demonstrated excellent process
performance with no flux residual remaining post-clean. ACM also announced that it has received a purchase order from a major Chinese manufacturer for the tool, which it expects to deliver in the first quarter of 2024.
|
• |
Dividend. ACM’s principal operating subsidiary, ACM Research
(Shanghai), Inc. (“ACM Shanghai”) (SSEC: 688082.SS), paid a dividend to its stockholders of RMB 0.372 per share for an aggregate total of approximately RMB 161.3 million (approximately $22.2 million) in the third quarter of 2023.
|
• |
Appointment of Ernst & Young Hua Ming LLP as Auditor for 2023. ACM announced that Ernst & Young Hua Ming LLP (“E&Y”) has been appointed as ACM’s independent registered public accounting firm to audit ACM’s consolidated financial statements and internal controls over financial reporting for
the fiscal year ending December 31, 2023. The engagement of E&Y became effective on September 20, 2023.
|
• |
Revenue was $168.6 million, up 26.1%, reflecting higher sales of
single wafer cleaning, Tahoe and semi-critical cleaning equipment; electro-chemical plating (“ECP”) (front-end and packaging), furnace and other technologies; and advanced packaging (excluding ECP), services and spares.
|
• |
Gross margin was 52.5%, up from 49.3%. Non-GAAP gross margin,
which excludes stock-based compensation, was 52.9%, up from 49.4%. Gross margin exceeded the range of 40% to 45% reflected in ACM’s long-term business model. The increase in
gross margin was due to a favorable product mix and improved gross margins for specific product lines. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
|
• |
Operating expenses were $55.3 million, an increase of 61.2%.
Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $45.3 million, up 39.2%. Operating expenses as a percent of revenue increased to 32.8% from 25.7%. Non-GAAP operating expenses as a percent of revenue
increased to 26.9% from 24.4%.
|
• |
Operating income was $33.2 million, up from $31.6 million. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $43.8 million, up from $33.5 million.
|
• |
Unrealized loss on short-term investments was $1.3 million. The
loss reflects the change in market value of the investments by ACM Shanghai in short-term investments. The value is marked-to-market quarterly and is excluded in the non-GAAP financial
metrics.
|
• |
Realized gain from sale of short-term investments was $0.7
million versus $1.1 million.
|
• |
Income tax expense was $0.7 million versus $10.5 million. As a
result of a change in Section 174 of the U.S. Internal Revenue Code of 1986, as amended, that became effective on January 1, 2022, ACM’s effective tax rate remains elevated,
due primarily to the requirement to capitalize and amortize previously deductible research and experimental expenses.
|
• |
Net income attributable to ACM Research, Inc. was $25.7 million,
up from $21.0 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized loss on short-term investments was $37.6 million, up from $28.2 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc.
was $0.39, up from $0.32. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on short-term investments, was $0.57, up from $0.42.
|
• |
Cash and cash equivalents were $207.1 million at September 30,
2023, versus $257.4 million at June 30, 2023. Cash and cash equivalents, plus restricted cash and time deposits, were $326.5 million at September 30, 2023, versus $376.1
million at June 30, 2023.
|
In the United States:
|
The Blueshirt Group
|
Yujia Zhai
|
|
+1 (860) 214-0809
|
|
yujia@blueshirtgroup.com
|
In China:
|
The Blueshirt Group Asia
|
Gary Dvorchak, CFA
|
|
+86 (138) 1079-1480
|
|
gary@blueshirtgroup.com
|
September 30, 2023
|
December 31, 2022
|
|||||||
|
(Unaudited)
|
|||||||
|
(In thousands)
|
|||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
207,101
|
$
|
247,951
|
||||
Restricted cash
|
560
|
500
|
||||||
Short-term time deposits
|
75,651
|
70,492
|
||||||
Short-term investment
|
21,844
|
20,209
|
||||||
Accounts receivable, net
|
248,477
|
182,936
|
||||||
Other receivables
|
36,126
|
29,617
|
||||||
Inventories, net
|
507,431
|
393,172
|
||||||
Advances to related party
|
1,164
|
3,322
|
||||||
Prepaid expenses
|
17,540
|
15,607
|
||||||
Total current assets
|
1,115,894
|
963,806
|
||||||
Property, plant and equipment, net
|
190,882
|
82,875
|
||||||
Land use right, net
|
8,299
|
8,692
|
||||||
Operating lease right-of-use assets, net
|
7,184
|
2,489
|
||||||
Intangible assets, net
|
2,163
|
1,255
|
||||||
Long-term time deposits
|
43,183
|
101,956
|
||||||
Deferred tax assets
|
16,486
|
6,703
|
||||||
Long-term investments
|
22,306
|
17,459
|
||||||
Other long-term assets
|
3,851
|
50,265
|
||||||
Total assets
|
$
|
1,410,248
|
$
|
1,235,500
|
||||
Liabilities and Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
$
|
33,911
|
$
|
56,004
|
||||
Current portion of long-term borrowings
|
6,717
|
2,322
|
||||||
Related party accounts payable
|
7,684
|
14,468
|
||||||
Accounts payable
|
136,675
|
101,735
|
||||||
Advances from customers
|
191,393
|
153,773
|
||||||
Deferred revenue
|
4,747
|
4,174
|
||||||
Income taxes payable
|
11,061
|
3,469
|
||||||
FIN-48 payable
|
6,487
|
6,686
|
||||||
Other payables and accrued expenses
|
80,400
|
52,201
|
||||||
Current portion of operating lease liability
|
2,876
|
1,382
|
||||||
Total current liabilities
|
481,951
|
396,214
|
||||||
Long-term borrowings
|
39,753
|
18,687
|
||||||
Long-term operating lease liability
|
4,308
|
1,107
|
||||||
Other long-term liabilities
|
6,106
|
7,321
|
||||||
Total liabilities
|
532,118
|
423,329
|
||||||
Commitments and contingencies
|
||||||||
Equity:
|
||||||||
Stockholders’ equity:
|
||||||||
Class A Common stock
|
6
|
5
|
||||||
Class B Common stock
|
1
|
1
|
||||||
Additional paid-in capital
|
620,210
|
604,089
|
||||||
Retained earnings
|
152,306
|
94,426
|
||||||
Statutory surplus reserve
|
16,881
|
16,881
|
||||||
Accumulated other comprehensive loss
|
(60,354
|
)
|
(40,546
|
)
|
||||
Total ACM Research, Inc. stockholders’ equity
|
729,050
|
674,856
|
||||||
Non-controlling interests
|
149,080
|
137,315
|
||||||
Total equity
|
878,130
|
812,171
|
||||||
Total liabilities and equity
|
$
|
1,410,248
|
$
|
1,235,500
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
2023
|
2022
|
2023
|
2022
|
|||||||||||||
(Unaudited)
|
(Unaudited)
|
|||||||||||||||
( In thousands, except share and per share data)
|
( In thousands, except share and per share data)
|
|||||||||||||||
Revenue
|
$
|
168,569
|
$
|
133,709
|
$
|
387,402
|
$
|
280,290
|
||||||||
Cost of revenue
|
80,055
|
67,742
|
190,263
|
150,480
|
||||||||||||
Gross profit
|
88,514
|
65,967
|
197,139
|
129,810
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Sales and marketing
|
16,803
|
13,133
|
37,579
|
27,494
|
||||||||||||
Research and development
|
26,151
|
15,678
|
60,244
|
44,391
|
||||||||||||
General and administrative
|
12,387
|
5,520
|
26,851
|
15,560
|
||||||||||||
Total operating expenses
|
55,341
|
34,331
|
124,674
|
87,445
|
||||||||||||
Income from operations
|
33,173
|
31,636
|
72,465
|
42,365
|
||||||||||||
Interest income
|
2,152
|
2,016
|
6,283
|
5,965
|
||||||||||||
Interest expense
|
(640
|
)
|
(419
|
)
|
(1,984
|
)
|
(986
|
)
|
||||||||
Realized gain from sale of short-term investments
|
656
|
1,136
|
8,569
|
1,136
|
||||||||||||
Unrealized loss on short-term investments
|
(1,319
|
)
|
(5,281
|
)
|
(4,428
|
)
|
(9,562
|
)
|
||||||||
Other income (expense), net
|
(2,150
|
)
|
7,207
|
156
|
9,949
|
|||||||||||
Income (loss) from equity method investments
|
(160
|
)
|
1,251
|
3,728
|
1,652
|
|||||||||||
Income before income taxes
|
31,712
|
37,546
|
84,789
|
50,519
|
||||||||||||
Income tax expense
|
(718
|
)
|
(10,470
|
)
|
(11,235
|
)
|
(14,138
|
)
|
||||||||
Net income
|
30,994
|
27,076
|
73,554
|
36,381
|
||||||||||||
Less: Net income attributable to non-controlling interests
|
5,315
|
6,072
|
13,905
|
8,927
|
||||||||||||
Net income attributable to ACM Research, Inc.
|
$
|
25,679
|
$
|
21,004
|
$
|
59,649
|
$
|
27,454
|
||||||||
Less: Dilutive effect arising from stock-based awards by ACM Shanghai
|
461
|
321
|
1,338
|
465
|
||||||||||||
Net income available to common stockholders, diluted
|
$
|
25,218
|
$
|
20,683
|
$
|
58,311
|
$
|
26,989
|
||||||||
Comprehensive income (loss):
|
||||||||||||||||
Net income
|
30,994
|
27,076
|
73,554
|
36,381
|
||||||||||||
Foreign currency translation adjustment, net of tax
|
4,015
|
(42,416
|
)
|
(21,831
|
)
|
(80,334
|
)
|
|||||||||
Comprehensive Income (loss)
|
35,009
|
(15,340
|
)
|
51,723
|
(43,953
|
)
|
||||||||||
Less: Comprehensive income (loss) attributable to non-controlling interests
|
7,768
|
(1,057
|
)
|
11,882
|
(4,378
|
)
|
||||||||||
Comprehensive income (loss) attributable to ACM Research, Inc.
|
$
|
27,241
|
$
|
(14,283
|
)
|
$
|
39,841
|
$
|
(39,575
|
)
|
||||||
Net income attributable to ACM Research, Inc. per common share:
|
||||||||||||||||
Basic
|
$
|
0.43
|
$
|
0.35
|
$
|
0.99
|
$
|
0.46
|
||||||||
Diluted
|
$
|
0.39
|
$
|
0.32
|
$
|
0.90
|
$
|
0.41
|
||||||||
Weighted average common shares outstanding used in computing per share amounts:
|
||||||||||||||||
Basic
|
60,219,218
|
59,360,790
|
59,953,144
|
59,123,895
|
||||||||||||
Diluted
|
65,450,941
|
65,612,665
|
64,834,051
|
65,629,273
|
`
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
||||||||||||||
2023
|
2022
|
2023
|
2022
|
|||||||||||||
($ in thousands)
|
||||||||||||||||
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
|
$
|
132,417
|
$
|
99,720
|
$
|
281,559
|
$
|
198,336
|
||||||||
ECP (front-end and packaging), furnace and other technologies
|
25,508
|
24,521
|
71,223
|
57,269
|
||||||||||||
Advanced packaging (excluding ECP), services & spares
|
10,644
|
9,468
|
34,620
|
24,685
|
||||||||||||
Total Revenue By Product Category
|
$
|
168,569
|
$
|
133,709
|
$
|
387,402
|
$
|
280,290
|
||||||||
2023
|
2022
|
2023
|
2022
|
|||||||||||||
Mainland China
|
$
|
168,302
|
$
|
131,180
|
$
|
375,528
|
$
|
273,585
|
||||||||
Other Regions
|
267
|
2,529
|
11,874
|
6,705
|
||||||||||||
Total Revenue By Region
|
$
|
168,569
|
$
|
133,709
|
$
|
387,402
|
$
|
280,290
|
Three Months Ended September 30,
|
||||||||||||||||||||||||||||||||
2023
|
2022
|
|||||||||||||||||||||||||||||||
Actual
|
SBC
|
Other non-
operating
adjustments
|
Adjusted
|
Actual
|
SBC
|
Other non-
operating
adjustments
|
Adjusted
|
|||||||||||||||||||||||||
(GAAP)
|
(Non-GAAP)
|
(GAAP)
|
(Non-GAAP)
|
|||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
168,569
|
$
|
-
|
$
|
-
|
$
|
168,569
|
$
|
133,709
|
$
|
-
|
$
|
-
|
$
|
133,709
|
||||||||||||||||
Cost of revenue
|
(80,055
|
)
|
(588
|
)
|
-
|
(79,467
|
)
|
(67,742
|
)
|
(130
|
)
|
-
|
(67,612
|
)
|
||||||||||||||||||
Gross profit
|
88,514
|
(588
|
)
|
-
|
89,102
|
65,967
|
(130
|
)
|
-
|
66,097
|
||||||||||||||||||||||
Gross margin
|
52.5
|
%
|
0.3
|
%
|
-
|
52.9
|
%
|
49.3
|
%
|
0.1
|
%
|
-
|
49.4
|
%
|
||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(16,803
|
)
|
(2,543
|
)
|
-
|
(14,260
|
)
|
(13,133
|
)
|
(349
|
)
|
-
|
(12,784
|
)
|
||||||||||||||||||
Research and development
|
(26,151
|
)
|
(3,421
|
)
|
-
|
(22,730
|
)
|
(15,678
|
)
|
(666
|
)
|
-
|
(15,012
|
)
|
||||||||||||||||||
General and administrative
|
(12,387
|
)
|
(4,029
|
)
|
-
|
(8,358
|
)
|
(5,520
|
)
|
(748
|
)
|
-
|
(4,772
|
)
|
||||||||||||||||||
Total operating expenses
|
(55,341
|
)
|
(9,993
|
)
|
-
|
(45,348
|
)
|
(34,331
|
)
|
(1,763
|
)
|
-
|
(32,568
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
33,173
|
$
|
(10,581
|
)
|
$
|
-
|
$
|
43,754
|
$
|
31,636
|
$
|
(1,893
|
)
|
$
|
-
|
$
|
33,529
|
||||||||||||||
Unrealized loss on short-term investments
|
(1,319
|
)
|
-
|
(1,319
|
)
|
-
|
(5,281
|
)
|
-
|
(5,281
|
)
|
-
|
||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
25,679
|
$
|
(10,581
|
)
|
$
|
(1,319
|
)
|
$
|
37,579
|
$
|
21,004
|
$
|
(1,893
|
)
|
$
|
(5,281
|
)
|
$
|
28,178
|
||||||||||||
Basic EPS
|
$
|
0.43
|
$
|
0.62
|
$
|
0.35
|
$
|
0.47
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.39
|
$
|
0.57
|
$
|
0.32
|
$
|
0.42
|
Nine Months Ended September 30,
|
||||||||||||||||||||||||||||||||
2023
|
2022
|
|||||||||||||||||||||||||||||||
|
Actual
|
SBC
|
Other non-
operating
adjustments
|
Adjusted
|
Actual
|
SBC
|
Other non-
operating
adjustments
|
Adjusted
|
||||||||||||||||||||||||
(GAAP)
|
(Non-GAAP)
|
(GAAP)
|
(Non-GAAP)
|
|||||||||||||||||||||||||||||
|
(In thousands)
|
|||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
387,402
|
$
|
-
|
$
|
-
|
$
|
387,402
|
$
|
280,290
|
$
|
-
|
$
|
-
|
$
|
280,290
|
||||||||||||||||
Cost of revenue
|
(190,263
|
)
|
(838
|
)
|
-
|
(189,425
|
)
|
(150,480
|
)
|
(383
|
)
|
-
|
(150,097
|
)
|
||||||||||||||||||
Gross profit
|
197,139
|
(838
|
)
|
-
|
197,977
|
129,810
|
(383
|
)
|
-
|
130,193
|
||||||||||||||||||||||
Gross margin
|
50.9
|
%
|
0.2
|
%
|
-
|
51.1
|
%
|
46.3
|
%
|
0.1
|
%
|
-
|
46.4
|
%
|
||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(37,579
|
)
|
(3,405
|
)
|
-
|
(34,174
|
)
|
(27,494
|
)
|
(1,277
|
)
|
-
|
(26,217
|
)
|
||||||||||||||||||
Research and development
|
(60,244
|
)
|
(4,831
|
)
|
-
|
(55,413
|
)
|
(44,391
|
)
|
(1,733
|
)
|
-
|
(42,658
|
)
|
||||||||||||||||||
General and administrative
|
(26,851
|
)
|
(5,592
|
)
|
-
|
(21,259
|
)
|
(15,560
|
)
|
(1,843
|
)
|
-
|
(13,717
|
)
|
||||||||||||||||||
Total operating expenses
|
(124,674
|
)
|
(13,828
|
)
|
-
|
(110,846
|
)
|
(87,445
|
)
|
(4,853
|
)
|
-
|
(82,592
|
)
|
||||||||||||||||||
Income from operations
|
$
|
72,465
|
$
|
(14,666
|
)
|
$
|
-
|
$
|
87,131
|
$
|
42,365
|
$
|
(5,236
|
)
|
$
|
-
|
$
|
47,601
|
||||||||||||||
Unrealized loss on short-term investments
|
(4,428
|
)
|
-
|
(4,428
|
)
|
-
|
(9,562
|
)
|
-
|
(9,562
|
)
|
-
|
||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
59,649
|
$
|
(14,666
|
)
|
$
|
(4,428
|
)
|
$
|
78,743
|
$
|
27,454
|
$
|
(5,236
|
)
|
$
|
(9,562
|
)
|
$
|
42,252
|
||||||||||||
Basic EPS
|
$
|
0.99
|
$
|
1.31
|
$
|
0.46
|
$
|
0.71
|
||||||||||||||||||||||||
Diluted EPS
|
$
|
0.90
|
$
|
1.19
|
$
|
0.41
|
$
|
0.64
|